Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease-Reference-Cited by-同舟云学术

Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease

Published:2009-04 Issue:4 Volume:71 Page:442-447
ISSN:0090-3019
Container-title:Surgical Neurology
language:en
Short-container-title:Surgical Neurology

Author:

Fujimura Miki,Mugikura Shunji,Kaneta Tomohiro,Shimizu Hiroaki,Tominaga Teiji

Publisher

Elsevier BV

Subject

Neurology (clinical),Surgery

Reference21 articles.

1. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion;Fujimura;Brain Res,1999

2. Neuroprotective effect of antioxidant in cerebral ischemia: role of neuronal apoptosis;Fujimura;Neurocrit Care,2005

3. Diagnostic value of perfusion-weighted MRI for postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease;Fujimura;Neurol Surg,2006

4. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease;Fujimura;Surg Neurol,2007

5. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease;Fujimura;Childs Nerv Syst,2007

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke and Disease Progression During Long-Term Follow-Up of Patients with Moyamoya Disease Older Than 50 Years;World Neurosurgery;2024-07

2. Long-term Outcomes of Combined Revascularization Surgery for Moyamoya Disease in the Elderly: A Single Institute Experience;Neurologia medico-chirurgica;2024-03-15

3. Safety of antiplatelet therapy during the perioperative period of revascularization surgery for moyamoya disease patients with ischemic onset;NAGOYA J MED SCI;2024

4. Impact of <i>RNF213</i> Variant Status on Revascularization Surgery for Moyamoya Disease: Implications for Precision Medicine;Surgery for Cerebral Stroke;2024

5. Risk Factors for Cerebral Hyperperfusion Syndrome After Combined Revascularization in Adult Patients with Moyamoya Disease;Current Neurovascular Research;2023-12